# AMD & Anti-VEGF Therapy

> Medical

Canonical page: [https://chrome-stats.com/d/id1511601192](https://chrome-stats.com/d/id1511601192)

## Overview

- **ID:** `id1511601192`
- **Platform:** Apple
- **Type:** Apple app
- **Status:** Available
- **Publisher:** Med Learning Group
- **Category:** Medical
- **Version:** 1.1.4
- **Last updated:** 2025-07-28
- **First published:** 2020-05-13
- **Size:** 162 MB
- **Data as of:** 2026-09-06
- **Store listing:** [Apple App Store](https://apps.apple.com/us/app/amd-anti-vegf-therapy/id1511601192)
- **Website:** [http://www.medlearninggroup.com/](http://www.medlearninggroup.com/)
- **Privacy policy:** [http://www.medlearninggroup.com/privacy-policy/](http://www.medlearninggroup.com/privacy-policy/)

## Description

Augmented reality animation briefly describing the pathophysiological retinal, as well as physically experienced visual changes associated with age-related macular degeneration, followed by treatment with anti-vascular endothelial growth factor (anti-VEGF) agents and its associated benefits and side effects.

## Rankings

- #1,669,621 — Overall

## Similar extensions and apps

- [Anti-VEGF Advances in Retina](https://chrome-stats.com/d/id6502371600)
- [DR & PRP Therapy](https://chrome-stats.com/d/id1512215656)
- [AMD Detection](https://chrome-stats.com/d/id6450021579) — 4.20 / 5
- [AMD\_eye](https://chrome-stats.com/d/id1453195553) — 5.00 / 5
- [MedicalEyeTrainer](https://chrome-stats.com/d/id1541833633)
- [Eye Disease Simulator](https://chrome-stats.com/d/id6664054188)
- [NEI-VR: See What I See](https://chrome-stats.com/d/id1459676305) — 4.90 / 5
- [Diabetic Retinopathy AR](https://chrome-stats.com/d/id1467432393) — 5.00 / 5
- [AR Eye](https://chrome-stats.com/d/id1004199290) — 5.00 / 5
- [Anu Reality EyeSim Mobile 2](https://chrome-stats.com/d/id1203454236)
- [Aira Vision Sim](https://chrome-stats.com/d/id1276859786) — 4.10 / 5
- [MaculaTester](https://chrome-stats.com/d/id334312308) — 4.50 / 5

---

Source: [Chrome-Stats](https://chrome-stats.com/d/id1511601192)